Telemedicine market in 'BRIC' countries set to grow to $418 million by 2014

19 August 2010

According to the new market research report, titled Telemedicine Market in Brazil, Russia, India, China (BRIC) - Advanced technologies, Global Forecast and published by MarketsandMarkets, the BRIC telemedicine is expected to reach a market size of $418.4 million by the year 2014, at a compound annual growth rate (CAGR) of 15.8% from 2009-2014.

Within this, the BRIC telemedicine technology market is expected to reach a size of $307.4 million by the year 2014 growing at a CAGR of 16.6% from 2009-2014 and BRIC telemedicine service market will reach $111 million in 2014 with CAGR of 13.8%.

The BRIC telemedicine market is witnessing a significant growth due to the increase in the number of patients suffering from chronic diseases such as chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), asthma, hypertension and diabetes.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >